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Abstract
Debilitating infectious diseases caused by Chlamydia are major contributors to the decline of Australia’s iconic native
marsupial species, the koala (Phascolarctos cinereus). An understanding of koala chlamydial disease pathogenesis and the
development of effective strategies to control infections continue to be hindered by an almost complete lack of species-
specific immunological reagents. The cell-mediated immune response has been shown to play an influential role in the
response to chlamydial infection in other hosts. The objective of this study, hence, was to provide preliminary data on the
role of two key cytokines, pro-inflammatory tumour necrosis factor alpha (TNFa) and anti-inflammatory interleukin 10 (IL10),
in the koala Chlamydia pecorum response. Utilising sequence homology between the cytokine sequences obtained from
several recently sequenced marsupial genomes, this report describes the first mRNA sequences of any koala cytokine and
the development of koala specific TNFa and IL10 real-time PCR assays to measure the expression of these genes from koala
samples. In preliminary studies comparing wild koalas with overt chlamydial disease, previous evidence of C. pecorum
infection or no signs of C. pecorum infection, we revealed strong but variable expression of TNFa and IL10 in wild koalas
with current signs of chlamydiosis. The description of these assays and the preliminary data on the cell-mediated immune
response of koalas to chlamydial infection paves the way for future studies characterising the koala immune response to
a range of its pathogens while providing reagents to assist with measuring the efficacy of ongoing attempts to develop
a koala chlamydial vaccine.
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Introduction
The koala (Phascolarctos cinereus) is an Australian arboreal
marsupial and the last surviving member of the family Phasco-
larctidae. Despite enjoying a unique position in Australian culture,
the koala faces the threat of localised extinction in many regions
along the Australian eastern seaboard [1,2,3]. The recognition of
this decline has recently lead to its inclusion in the threatened
species list by the Australian Government Department of
Sustainability, Environment, Water, Population and Communities
[4]. Several threats are contributing to this decline, including
habitat destruction [1], natural disasters [5], dog attacks [6] motor
vehicle accidents [7] and disease. Of the many threatening
processes affecting the koala, infectious diseases appear to have the
greatest impact with a recent study showing that if diseases in this
host could be reduced by up to 50%, then declining koala
populations had the potential to be stabilised [8].
Chlamydia pecorum is the main aetiological agent of infectious
disease in the koala with studies reporting around 60–98%
prevalence of chlamydial infection in certain free range koala
populations [9,10,11,12]. C. pecorum infection in koalas has been
associated with cystitis, proliferative conjunctivitis and chronic,
fibrotic disease of the urogenital tract leading to infertility and
death [13,14,15,9,16,12]. In non-koala hosts, the role of cell
mediated immunity (CMI) as the major immune response
generated by the host against chlamydial infection is acknowl-
edged [17,18,19]. Inflammation, driven by the effects of in-
flammatory cytokines, has also been linked to the manifestation of
disease [20].
A major hurdle in our understanding of the role of the koala
immunological response in relation to these diseases is the paucity
of immunological reagents for this host. In their absence, current
assays employed to characterise the marsupial immune response
rely on reagents from placental mammals, which exhibit only weak
cross-reactivity in marsupial systems [21]. The ideal targets for
measuring local and systemic immune response to intracellular
pathogens are cytokines; soluble immune regulators produced by
cells of both the innate and adaptive immune systems. In this
study, we aimed to develop koala-specific quantitative real time
PCR (qrtPCR) assays and perform preliminary studies on the
expression of two key cytokines, pro-inflammatory cytokine,
TNFa, as well as a key anti inflammatory cytokine, IL10. TNFa
is a trimeric pro-inflammatory polypeptide synthesised principally
by macrophages in response to bacterial toxins, inflammatory
products and other invasive stimuli [22]. IL10 is a dimeric
polypeptide secreted by cells of the innate and adaptive immune
system, the main function of which is to limit and ultimately
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terminate inflammatory responses [23,24]. The partial sequence of
a house-keeping gene, glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), was also determined for use as an internal control.
qrtPCR assays were then developed to measure these two key
cytokines within koala peripheral blood mononuclear cells
(PBMCs) revealing strong expression in koalas with current signs
of chlamydial disease.
Materials and Methods
Ethics statement
The collection of blood samples from koalas admitted to
Australia Zoo Wildlife Hospital, Beerwah was performed by
qualified veterinarians. Blood was collected from all animals
following anaesthesia for other routine veterinary procedures and
treatment. The collection and subsequent analysis of these koala
blood samples was approved by the Queensland University of
Technology Animal Ethics Committee (Approval No.
0700000845).
Bioinformatics analysis of koala cytokine sequences
Multiple sequence alignments were carried out using the
Geneious Alignment program in the Geneious Pro 5.6.5 software
and GeneDoc version 2.7.000 software. Phylogenetic trees were
constructed using Jukes Cantor, UPGMA tree build method in
Geneious Pro 5.6.5 software. TNFa and IL10 sequences were
obtained from GenBank (GenBank ID): brushtail possum IL10
(AF026277), North American opossum IL10 (XM_003340167),
mouse IL10 (M37897), sheep IL10 (Z29362), deer IL10 (U11767),
horse IL10 (EU438771), cat IL10 (AF060520), monkey IL10
(DQ890063), human IL10 (AY029171), dog IL10
(NM_001009209), chicken IL10 (AY647438), Pigeon IL10
(AB618540), brushtail possum TNFa (AF016102), North Amer-
ican opossum TNFa (AJ286832), tammar wallaby TNFa
(AF055915), red kangaroo TNFa (AJ286833), mouse TNFa
(EU682384), sheep TNFa (NM_001024860), deer TNFa
(U14683), horse TNFa (NM_001081819), cat TNFa
(NM_001009835), monkey TNFa (DQ902477), human TNFa
(AB451492), dog TNFa (NM_001003244) and chicken TNFa
(AY765397).
Sample collection
PBMCs were harvested from koala blood samples for use in this
study. 5–6 ml of blood was collected in 6 ml EDTA blood tubes
from koalas brought into the hospital and stored at 4uC until
further processing on the same day. Swabs were collected from the
conjunctiva of the left eye, right eye, urogenital sinus (females) and
urethra (males) using aluminium shafted cotton tipped swabs
(Copan, Interpath Services, Melbourne).
Koala lymphocyte stimulation assay
PBMCs from the blood samples were separated using Ficoll
Paque gradient centrifugation at 400 g for 20 mins (GE
Healthcare, Rydalmere, Australia). After 2–3 washings with
PBS, the cells were suspended in 1 ml of RPMI 1640 T cell
media, supplemented with 5% foetal calf Serum, antibiotics and b-
mercaptoethanol (0.001 M). The cells were then diluted to
a concentration of 26106 cells/ml in the media and mixed with
an equal volume of T cell mitogens, PMA (1 mg/ml) and
Ionomycin (50 ng/ml) to stimulate koala PBMCs. To optimise
the target gene expression, PBMCs were stimulated for different
durations of time (24, 48 and 72 hours). The cell suspension and
mitogen were added at a 1:1 concentration for a final volume of
200 ml/well to standard 96-well microtitre plates (Nunc) and
incubated at 37uC in 5% CO2. At the end of the incubation
period, cells were harvested from the cell suspension by
centrifugation at 400 g for 10 mins and suspended in 1 ml of
Trizol reagent (Invitrogen, Victoria, Australia) and left at room
temperature for 5 mins to homogenise. Samples were then stored
at 280uC for downstream applications.
RNA extraction and reverse transcription
RNA extraction was performed from the PBMCs suspended in
Trizol reagent using the RNeasy Mini Kit (Qiagen, Victoria,
Australia) according to the manufacturer’s instructions. The
concentration and purity of RNA was determined using a Nano-
drop ND-1000 Spectrophotometer. RNA degradation was
checked by running the sample on a 2% agarose gel with the
presence of two distinct bands depicting 18S and 28S rRNA
indicating the quality of RNA isolation and absence of any
degradation. In order to eliminate any possible DNA contamina-
tion, the RNA preparation was subjected to DNase digestion using
Amplification Grade Deoxyribonuclease I (Sigma Aldrich, NSW,
Australia) and immediately processed for cDNA synthesis. The
reverse transcription reaction using random hexamer primers was
performed using the Transcriptor First Strand cDNA Synthesis
Kit (Roche, NSW, Australia) according to the manufacturer’s
instructions. The cDNA obtained was used as template for
conventional PCR and qrtPCRs.
Koala cytokine sequence cloning and sequencing
Primers for koala cytokine gene detection were designed based
on alignment of homologous gene sequences from other species. A
sequence alignment was carried out for the coding sequence of
each gene from various species accessioned in Genbank, with
Trichosorus vulpecula (Australian common brushtail possum) as the
reference sequence for primer design. For IL10 primer design,
brushtail possum, dog, cat, horse, pig, human, rat, rabbit and
mouse IL10 sequences were used for alignment construction.
Similarly, for TNFa primer design, brushtail possum, red
kangaroo and wallaby TNFa sequences were used. The primers
were designed along highly conserved regions to maximise chances
of amplifying the corresponding gene in the koala (data not
shown).
Upon successful amplification, PCR product of the expected
size was cloned into a plasmid using Promega pGEM-T Easy
Vector Systems I. In order to validate the sequences, a minimum
of five clones were grown overnight at 37uC in LB medium (Luria-
Bertani Medium) with ampicillin (100 mg/ml) with intermittent
shaking. DNA was extracted using the Purelink Quick Plasmid
Miniprep Kit (Invitrogen, Victoria, Australia). Success of cloning
was determined by digesting the plasmid DNA using Restriction
Endonuclease EcoR I (Roche, Applied Science, Germany). A single
digest with EcoR1 releases inserts cloned into the pGEM-T Easy
Vector. The digested product was then run on a 1.5% agarose gel
along with the uncut plasmid. The presence of a band of the
expected size indicated successful insertion of the target sequence
into the vector. The products were then sequenced at Australian
Genome Research Facility using the AB 3730xl platform.
Design and optimisation of koala cytokine quantitative
SYBR Green I RT-PCR assays
Koala TNFa and IL10 cytokine mRNAs identified as part of
this study were used to design primers for the qrtPCR assay using
Primer ExpressH Software v3.0 by Applied Biosystems targeting
180 bp and 72 bp regions, respectively. The sequences for each
primer used in qrtPCR assays are summarised in Table 1.
Koala TNFalpha and IL10 Responses to Chlamydia
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Furthermore, primers which would amplify a PCR product
spanning over two postulated exons based on comparison of these
locations in tammar wallaby or human sequences were designed in
order to avoid any co-amplification of contaminating genomic
DNA in the reaction mixture (Figure 1).
The target cytokine genes were optimised into qrtPCR assays
using SYBR Green I dye chemistry for gene quantification at the
mRNA level. Assay efficiency was determined by constructing
standard curves for the two cytokines using purified PCR product
serial dilutions of known concentration at 102, 104, 106, 108 gene
copy numbers. Conventional PCR with each gene-specific primer
pair was used to prepare serially diluted qrtPCR standards (102,
104, 106 and 108). Approximately 100 ml of the amplified PCR
product was run on a 1.5% agarose/TBE gel to confirm successful
amplification. Corresponding bands were excised from the gel and
solubilised using the High Pure PCR Product Purification Kit
(Roche, Applied Science, Germany) as per the manufacturer’s
instructions. Purified PCR product was checked for quality and
concentration using Nanodrop ND-1000 Spectrophotometer at
absorbance of 260 and 280 nm wavelengths. The number of
molecules of the product was calculated using Avagadro’s formula.
All reactions were carried out on a Corbett Rotor Gene 6000
real time PCR machine at a final volume of 20 ml, with 1 unit of
Fastart Taq Polymerase (Roche), 2 ml of 25 mM MgCl2 (Roche),
2 ml of 10 x buffer (Roche), 1 ml of 10 mm dNTPs (Roche), 3 ml of
1/10000 SYBR Green and 0.6 ml each of 5 mM forward and
reverse primers. After an initial incubation of 95uC for 10 mins, 40
cycles of 10 s at 95uC, 25 s at 56uC and 15 s of 72uC were carried
out for IL10 qrtPCR. For TNFa qrtPCR, after an initial
incubation of 95uC for 10 mins, 40 cycles of 10 s at 95uC, 20 s
at 54uC and 15 s of 72uC were carried out. All samples were tested
in triplicate. Reactions were carried out at a final volume of 20 ml.
Figure 1. The exon distribution and primer position of koala TNFa (a), IL10 (b) and GAPDH (c) genes when in alignment with other
marsupial and human sequences of the corresponding genes. The forward and reverse primer sequences used in the RT-PCR assays are
highlighted in green and red, respectively. The PCR product has been designed such that it spans over an intron-exon junction.
doi:10.1371/journal.pone.0059958.g001
Table 1. qrtPCR primers for TNFa, IL10 and GAPDH genes.
Gene Forward Primer 59–39 Reverse Primer 59–39 Target
TNF a GAGACGTAGAGCTAGCAG TGCCAAGAAAATCTGTGGAC 180 bp
IL 10 TGGGCTCTTTAGGCGAGAAG CAGGGCAGGAATCTGTGACA 72 bp
GAPDH GGACTCATGACCACAGT CCATCACGCCACAGC 70bp
doi:10.1371/journal.pone.0059958.t001
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Mastermix with no cDNA was used as the no template control
whereas water was used as the negative control.
In order to facilitate comparison between animals and
experiments and to normalise the variable amount of starting
material used for each experiment, GAPDH, a house-keeping
gene, was chosen as reference gene for the qrtPCR assay. The
koala GAPDH gene was isolated using consensus primers designed
from available GAPDH gene sequences. The real time GAPDH
primers targeted a 70 bp region for which standards of known
concentrations of 102, 104, 106 and 108 copy numbers were
prepared as previously described. The reactions were carried out
in 20 ml final volume. An initial incubation of 95uC for 10 mins
was followed by 40 cycles of denaturation for 10 s at 95uC, 15 s
annealing at 52uC and 20 s extension at 72uC for GAPDH
qrtPCR assay. The target cytokine genes were normalised to
GAPDH by the 22DDCT method, where DDCT = (Ct of target –
Ct of GAPDH) at any time point – (Ct of target – Ct of GAPDH)
at time zero hour [25].
TNFa and IL10 mRNA production in koala PBMCs upon in
vitro exposure to chlamydial antigens
In order to determine TNFa and IL10 production levels in
koalas upon exposure to chlamydial antigens, blood samples were
collected from 10 koalas brought into Australia Zoo Wildlife
Hospital. PBMCs were processed from the blood samples and
cultured in the presence of UV inactivated C. pecorum. A 500 ml
stock of semi-purified C. pecorum G [26] was UV inactivated as
described by Rey-Ladino et al. [27] and further diluted 1/20
dilution in RPMI 1640 T cell media. The plasma samples from
these animals were stored at 280uC for use in western blot
analysis. Cells were then cultured in the presence of UV
inactivated C. pecorum G at 1:1 ratio for durations of 12, 24 and
48 hours. Unstimulated cells were collected at the start of the
experiment to calculate baseline data for qrtPCR assays. At the
end of the stimulation periods, RNA extraction and cDNA
synthesis was performed and TNFa, IL10 and GAPDH mRNA
expression was determined using our koala specific qrtPCR assays,
designed as part of this study.
C. pecorum species specific PCR screening and Western
Blot analysis
To determine the current and previous C. pecorum infection
status of koalas analysed as a part of this study, swab samples (eyes,
urogenital tract) and blood samples were collected from 10 koalas
that presented to the Australian Wildlife Hospital for veterinary
care (Table 2).
The presence of C. pecorum DNA in koala swabs was determined
using a previously described C. pecorum species-specific qrtPCR
[28] targeting a 202 bp region of the 16S rRNA region using
primers 16Sf (59 – AGTCGAACGGAATAATAATGGCT –39)
and 16Sr (59 – CCAACAAGCTGATATCCCAC –39). Briefly,
DNA was extracted from swab samples following vortexing and
centrifugation and then used as a template in the qrtPCR. 25 ml
qrtPCR reactions were performed in duplicates with 3 ml of
extracted DNA template, 1 unit of Fastart Taq Polymerase
(Roche), 2.5 ml of 25 mM MgCl2 (Roche), 2 ml of 10 x buffer
(Roche), 0.6 ml of 10 mm dNTPs (Roche), 3 ml of 1/10000 SYBR
Green and 0.6 ml each of 10 mM forward and reverse primers.
Reactions were carried out in a Corbett Rotor Gene 6000 real
time PCR machine with an initial denaturation at 95uC for
5 mins, followed by 94uC for 30 s, annealing at 57uC for 15 s and
extension at 72uC for 25 s for 40 cycles. Standards with 108, 106,
104 and 102 of C. pecorum 16S rRNA genomic DNA copy numbers
were used as calibrators for the assay. High resolution melt
analysis was performed to confirm the C. pecorum specific PCR
product with a melting temperature range between 82uC and
85uC [29].
Western blots were performed using recombinant C. pecorum
His-tagged major outer membrane protein (MOMP) A, F and G
antigens as described by Kollipara et al. [30] to detect the
presence of C. pecorum MOMP-specific koala IgG antibodies in the
koala plasma samples.
Statistics
Graph-Pad Prism version 5 (Graph Pad Software, Lajolla, CA,
USA) was used to perform statistical analyses. Unpaired t- test with
the P value set at ,0.05 was used to analyse significance of TNFa
and IL10 mRNA expression relative to GAPDH among the
different groups of koalas analysed.
Results
Koala cytokine mRNA sequence identification and
analysis
This is the first study to report the sequences of any koala
cytokine. As the starting point for this study, consensus primers
were designed against partial sequences for the TNFa gene from
brushtail possum, red kangaroo and wallaby. Similarly, for IL10
primer design, brushtail possum, dog, cat, horse, pig, human, rat,
rabbit and mouse IL10 sequences were used. Following successful
PCR amplification and sequencing of the cloned PCR products,
958 bp of koala TNFa (GenBank accession number – JX845580)
and 479 bp of koala IL10 (GenBank accession number –
JX845581) mRNA were identified (Figure 1A and 1B). BLAST
analysis of available sequences and comparison of the TNFa
sequence in the koala with sequences from other marsupials,
mammals and avians, shows that, not surprisingly, the koala
sequences are more similar to the red kangaroo (90.1%), tammar
wallaby (88.7%), North American opossum (80.7%) and brushtail
possum (84.4%) sequences than they are to the mammalian or
avian TNFa sequences. A comparison of the koala IL10 sequence
revealed a similar picture, with the highest homology observed
with the marsupial species sequences available from, brushtail
possum (91%) and North American opposum (83.9%), compared
to the mammalian or avian species.
The total length of TNFa mRNA in humans and tammar
wallaby is 1669 bp (GenBank: NM_000594) and 1771 bp
(GenBank: AY853666) respectively. The tammar wallaby TNFa
gene consists of 4 exons and 3 introns. We cloned 958 bp of the
koala TNFa nucleotide sequence which corresponds to the entire
first, second and third exons of the sequence as well as
approximately 65% of exon 4 (Figure 1A). This covers the entire
59 untranslated region and the complete coding sequence for the
protein [31]. An analysis of the koala TNFa amino acid sequence
with reference to the human TNFa reveals several structural
similarities (Figure 2A). The predicted transmembrane and
intracytoplasmic regions show considerable homology [31] and
the receptor binding sites are highly conserved as well [32].
The complete mRNA of brushtail possum IL10 is 1604 bp long
(GenBank: AF026277) which has 91% similarity to the 479 bp of
the cloned IL10 koala sequence. Of the five exon regions of the
brushtail possum IL10 gene, the available koala sequence spans
exons 1, 2, 3, 4 and 5 (Figure 1B). The koala IL10 sequence cloned
as part of this study lies within the coding sequence for the protein
when compared to the brushtail possum IL10 coding sequence.
The brushtail possum IL10 coding sequence translates to a 175
amino acid protein, whereas the koala IL10 sequence translates to
Koala TNFalpha and IL10 Responses to Chlamydia
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a 159 amino acid sequence. An evaluation of the koala IL10
amino acid sequence with reference to the human IL10 sequence
reveals conservation of several key features. Four cysteine residues
that form intramolecular disulphide bridges in human IL10
protein are conserved in the deduced koala IL10 sequence
(Figure 2B). Similarly, residues that are important for IL10
structural stabilisation [33] are also conserved across the two
species (Figure 2B).
The relationship of the koala TNFa and IL10 sequences with
other marsupial and mammalian TNFa and IL10 sequences is
illustrated in a phylogenetic tree (Figures 3A and 3B). It shows that
the marsupial, mammalian and avian TNFa and IL10 sequences
have evolved along different lines, with the koala sequences
forming a distinct clade with other marsupial sequences, away
from placental mammals and birds.
Development of koala cytokine qrtPCR assays
qrtPCR assays were developed using koala TNFa, IL10 and
GAPDH sequences to measure their expression in koala periph-
eral blood samples. The primers for all three genes were designed
such that the amplicons would span over at least one intron-exon
junction, thereby eliminating any chances of amplifying contam-
inant DNA left in the sample. R2 values for all assays were found
to be 0.99. The CT value of the standards used was found to be
similar in consecutive runs, thereby confirming the reproducibility
of the assay. Moreover, agarose gel visualisation of representative
replicates from RT-PCR reactions revealed appropriately-sized
bands. Efficiency of the reaction was calculated as 10(21/slope). All
three assays achieved greater than 90% efficiency and could detect
,102 gene copies. These values illustrate that the RT-PCR assay
for the TNFa, IL10 and GAPDH gene are optimised and can be
used for quantification of these genes in an unknown sample.
TNFa and IL10 expression in koala PBMCs stimulated
with UV- inactivated C. pecorum
To provide preliminary data on the koala TNFa and IL10
response to chlamydial infection, blood samples were collected
from 10 koalas presenting to the Australia Zoo Wildlife Hospital
for veterinary care. Based on the results and the presence of overt
signs of koala chlamydiosis, the 10 koalas were divided into three
groups: Group I (n = 4) – koalas with current clinical signs of
chlamydiosis; Group II (n = 3) – C. pecorum PCR and/or western
blot positive koalas without overt signs of chlamydiosis; and Group
III (n = 3) – PCR and/or western blot negative koalas with no
overt signs of chlamydiosis (Table 2).
Four koalas (Group I) included in this analysis presented with
signs consistent with active chlamydial infection (i.e. conjunctivitis
and/or cystitis) whereas the remaining six animals were brought
into the hospital for conditions other than chlamydial infection
(Table 2). Ocular and urogenital swabs were collected from all
animals and screened for the presence of C. pecorum DNA using
a species-specific 16S rRNA qrtPCR, as previously described
(Wan et al., 2011).
Of the Group I animals, the urogenital tract swabs of two
animals (#42983 and #42096) presenting with cystitis were found
to be qrtPCR positive (31 and 588 16S rRNA copies/mL of
extracted DNA, respectively), indicating mild to moderate
shedding of C. pecorum from these anatomical sites (Wan et al.,
2011). All animals in groups II and III were qrtPCR negative for
C. pecorum DNA as was the remaining animals from Group I
(#42082 and #42980). To evaluate previous exposure to a C.
pecorum infection, the presence of koala-C. pecorum specific IgG
antibodies was determined for all animals by Western blot using
a panel of recombinant C. pecorum MOMPs. All four Group I
animals were found to be positive for C. pecorum MOMP-specific
IgG (data not shown). Of the remaining animals, three animals
without overt signs of chlamydiosis were also found to be Western
blot positive (Group II) while the rest were Western blot negative
(Group III).
PBMCs isolated from all koalas were stimulated with UV-
inactivated semi-purified C. pecorum elementary bodies for 12, 24
and 48 hours and TNFa and IL0 mRNA expression was
measured using our koala specific qrtPCR assays, developed as
part of this study. On stimulation with UV inactivated C. pecorum,
significantly higher mRNA expression levels (P,0.05) for IL10
was observed in PBMCs obtained from Group I animals
compared to animals in Groups II and III (Figure 4). However,
for TNFa mRNA expression a significant difference (P,0.05) in
expression levels was observed only between Group I and II
animals. With one as the baseline for unstimulated PBMCs at
0 hour, a 10 to 50 fold increase was observed in TNFa mRNA
expression levels relative to GAPDH at the 48 hours post-
Table 2. Clinical presentation and C. pecorum infection status for animals analysed as a part of this study.
Animal ID Clinical Presentation C. pecorum species -specific qrtPCR result C. pecorum MOMP Western Blot
Group I (n =4)
#42983 Cystitis Positive Positive
#42096 Cystitis Positive Positive
#42082 Conjunctivitis NEGATIVE Positive
#42980 Cystitis NEGATIVE Positive
Group II (n =3)
#40520 Dog attack NEGATIVE Positive
#42097 Vehicle hit NEGATIVE Positive
#38940 Gut disease NEGATIVE Positive
Group III (n = 3)
#42012 Vehicle hit NEGATIVE NEGATIVE
#42943 Vehicle hit NEGATIVE NEGATIVE
#53470 Healthy NEGATIVE NEGATIVE
doi:10.1371/journal.pone.0059958.t002
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stimulation timepoint in Group I animals. Similarly, a 100 to 350
fold increase in IL10 mRNA relative expression (Figure 4) could
be observed in the same animals. On average, IL10 mRNA
expression levels were observed to be higher (P,0.05) than TNFa
mRNA expression levels in Group I animals (with current
chlamydial disease). In either Group II or Group III animals, no
statistically significant difference could be observed between koala
TNFa and IL10 mRNA expression, except for the expression
(P,0.05) of IL10 mRNA at 48 hour time point stimulation which
was caused by a high IL10 mRNA expression by an individual
animal included in Group III.
Discussion
Very little is known about the immune system of the koala,
confounding efforts to understand and develop strategies to control
chlamydial infections in this host. Early studies suggested that the
koala is an ‘immunologically lazy’ animal, as delayed humoral
immune responses were observed, when compared to placental
mammals [34]. However, these reports have not been supported
by data from our recent studies evaluating the efficacy of
a prototype koala chlamydial vaccine [35,30] as significant
humoral and CMI responses to chlamydial antigens, with similar
kinetics, magnitude and duration as seen in other species can be
readily detected. A limitation of these studies, however, was an
inability to profile the expression of cytokine genes associated with
the CMI response since no reagents were available for use in these
studies. Hence, the main aim of this study to develop the first
reagents to measure cytokine expression in the koala and to
provide preliminary data on their response to C. pecorum infection.
Before this study, no information was available regrading any
koala cytokine gene. Hence, as a first step, nucleotide sequences of
the TNFa and IL10 cytokine genes were determined and used to
design qrtPCR based assays. The expression of these cytokines was
then compared to the housekeeping gene, GAPDH, in order to
correct the variation in input RNA in different samples. The
efficiency of the qrtPCR assays was shown to be reproducible over
subsequent experiments, hence implying the reproducibility of the
assays.
The cloned partial sequence of the koala TNFa nucleotide
sequence has more than 80% homology to other marsupial TNFa
sequences. This level of variability is similar to what is observed
among the TNFa sequences of placental mammals (.80%; data
not shown). Similar to koala TNFa, the IL10 nucleotide sequence
also has more than 80% homology to the two available marsupials
IL10 sequences which is comparable to the extent of similarity
between the IL10 sequences of the placental mammals. It is this
level of conservation at the nucleic acid level of the TNFa and
Figure 2. Amino acid sequence alignment of koala, brushtail possum and human TNFa sequences. (a) Koala TNFa sequence
characterisation is done with reference to the human TNFa sequence. Presequence comprising of 76 amino acids and the secreted form of 156 amino
acids is indicated by the horizontal red and green lines respectively. The hydrophobic transmembrane region and the intracytoplasmic region are
marked out in red and green boxes respectively [31]. Asterisks indicate the receptor binding sites of the protein [32]. (b) Koala IL10 sequence
characterisation is done with reference to the human IL10 sequence. Cysteine residues which form intramolecular disulphide bonds in human IL10
are marked in red boxes. Residues important for structural stabilisation are marked in green boxes. The six a-helices of the IL10 monomer are
depicted by dotted blue lines [33].
doi:10.1371/journal.pone.0059958.g002
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IL10 cytokines among different species, as well as within the
marsupials that has enabled their successful cloning in the koala
based on the principal of consensus primer design. Hence, this
methodology can be employed for the cloning of other koala
cytokines for which corresponding marsupial sequences are
available. Even though the PCR primers for this assay were
designed specifically for koala TNFa and IL10, we cannot exclude
the possibility that these may cross-react with other marsupial
sequences – a possibility that may open up opportunities for
studying related hosts that also lack genomic resources.
In a preliminary study to evaluate the role of these cytokines in
koala chlamydial infections and disease, TNFa and IL10 responses
of koala PBMCs, isolated from three cohorts of koalas was
measured (Figure 4). Although high levels of variability was
observed within each group, there was a significantly high
expression (P,0.05) of TNFa and IL10 mRNA in animals with
current chlamydial disease when compared to the remaining
animals in the study. Elevated TNFa levels have been observed
and associated with conditions such as atherosclerosis and
coronary heart disease resulting from C. pneumoniae infection
[36,37]. IL10, on the other hand, is an anti-inflammatory cytokine
known to play a critical role in chronic infections caused by intra-
cellular organisms. During chlamydial infection, high IL10
production has been associated with pathogenesis [38,39] in
a mouse model of C. trachomatis infection. Moreover, elevated levels
of IL10 have also been observed in women with disease caused by
C. trachomatis [40,41]. The observation of high levels of IL10 gene
activation in the diseased koalas from Group I may provide the
first glimpse at understanding the differences in immune response
between asymptomatically infected koalas and koalas with
chlamydial disease presentations. In the studies in other hosts,
an increase in IL10 production corresponded with a decrease in
interferon-gamma (IFNc) production, which is the principle Th1
cytokine that provides protection against chlamydial infection
Figure 3. Phylogenetic tree of (a) TNFa and (b) IL10 nucleotide sequence constructed using Geneious Pro 5.6.5 using Jukes Cantor,
UPGMA tree build method with 1000 bootstrap repeat value.
doi:10.1371/journal.pone.0059958.g003
Figure 4. TNFa and IL10 gene expression in koala PBMCs stimulated with UV inactivated C. pecorum in Group I, II and III animals.
Samples were collected at 0, 12, 24 and 48 hours. Results are expressed as fold increased compared to GAPDH.
doi:10.1371/journal.pone.0059958.g004
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[42]. IL10 is known to suppress Th1 cytokine response by
inhibiting TNFa and IFNc, the latter two having a synergistic
effect on each other [23]. Even though a 300 fold increase in IL10
mRNA expression compared to a 60 fold increase in TNFa
expression in koalas with chlamydial disease analysed in this study
may be an indication of a similar role played by IL10 expression in
koalas as well, a conclusive link can be established only after
analysing the IFNc expression in these animals. No reagents are
currently available to measure the latter cytokine, however.
Several factors will need to be considered in future investiga-
tions of the koala immune response to chlamydial infection. These
include the site of the current chlamydial infection, the genetic
diversity of the infected C. pecorum strains [26,30] as well as the age
and gender of the animal, beyond the fact that these animals are
genetically out-bred. The genetic diversity of C. pecorum MOMP,
for instance, may partially explain why several animals in Group
III produced low levels of TNFa and IL10 expression, re-
spectively, despite being negative by our MOMP-based western
blot assays. Other host factors that will also need to be considered
include polymorphisms in the IL10 promoter gene and the TNFa,
coding sequence which has been shown to affect human immune
responses to C. trachomatis infection [43,44]. We did not examine
the presence of genetic variation between the IL10 and TNFa
sequences between different koalas but this should be a focus for
further investigations. The current study analysed in vitro TNFa
and IL10 production by koala PBMCs on exposure to UV-
inactivated C. pecorum. However, it is known that chlamydial
disease is a manifestation of localised infection and cytokines have
a localised mechanism of action. Hence, along with the analysis of
more cytokines to better understand the immune response of the
koala to chlamydial infection, examining local cytokine production
at the site of infection will provide valuable information regarding
chlamydial disease in the koala.
Conclusions
The identification of the first cytokine sequences from the koala
and the development of much-needed immunological reagents in
this study have provided critical tools and much-needed baseline
data on the koala immune system to begin to allow us to elucidate
the role of the immune response to infections by this highly
pathogenic bacterial infection. Broadening our understanding of
the koala immune system is significant due to the ongoing and
rapid declines of this native marsupial species across various parts
of Australia. Direct and rapid interventions via vaccination of wild
koalas is likely required to stabilise declining koala populations
from disease threats and these assays, along with the identification
of additional koala cytokines, will be critical in evaluating the
efficacy of these strategies.
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